Fadlo Raja Khuri
Fadlo Raja Khuri publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Head and Neck Cancer Studies and Lung Cancer Research Studies.
- World rank
- #39,334 of 7,710,434 ranked researchers
- Rank in United States
- #15,062 of 1,627,098
- Works
- 1,065
- Citations
- 78k
- Citations per work
- 73.3
What does Fadlo Raja Khuri research?
Fadlo Raja Khuri's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (32%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences40437.9%
- Medicine40437.9%
- Life Sciences33831.7%
- Everything else32430.4%
- 1Molecular Biology25% of their works
- 2Oncology16% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Cancer Research7% of their works
- 5Otorhinolaryngology4% of their works
- 6Surgery3% of their works
Research topics
Which keywords describe Fadlo Raja Khuri's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Radiotherapy, Apoptosis and Cancer Therapy.
- Retinoic Acid
- Cell Death
- p53
- mTOR
- Lung Cancer
- Small-Cell Lung Cancer
- Oropharyngeal Cancer
- Cancer Therapy
- Radiotherapy
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Apoptosis
- Human Papillomavirus
- Genomic Profiles
- CT Screening
- Signaling
- Cell Cycle
- Bcl-2 Family
- Acute Promyelocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Trials2492 topics
- Targeted Therapy2492 topics
- Chemotherapy2453 topics
- ALK Inhibitors1621 topic
- EGFR Mutations1621 topic
- Radiotherapy1582 topics
- Apoptosis1082 topics
- Cancer Therapy1082 topics
- Human Papillomavirus921 topic
- Oropharyngeal Cancer921 topic
- Genomic Profiles871 topic
- Small-Cell Lung Cancer871 topic
- CT Screening661 topic
- Lung Cancer661 topic
- Signaling611 topic
- mTOR611 topic
- Cell Cycle551 topic
- p53551 topic
- Bcl-2 Family531 topic
- Cell Death531 topic
- Acute Promyelocytic Leukemia501 topic
- Retinoic Acid501 topic
Where does Fadlo Raja Khuri work?
Fadlo Raja Khuri's main affiliation in the publication record is Emory University, United States.
How many publications and citations does Fadlo Raja Khuri have?
OpenAlex counts 1,065 works and 78,071 citations for Fadlo Raja Khuri, an h-index of 119, ranking #39,334 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fadlo Raja Khuri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.